← Back
Data updated: Mar 10, 2026
USWM
OncologyGastroenterology
USWM is a specialty pharmaceutical company focused on Oncology, Gastroenterology. Key products include IWILFIN.
1979
Since
4
Drugs
-
Trials
4
Approved (2yr)
Recent Activity
IWILFIN 2024-11-26
Labeling
REVONTO 2024-11-22
Labeling
MELPHALAN HYDROCHLORIDE 2024-10-29
MELPHALAN HYDROCHLORIDE 2024-05-23
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 92%
0 drugs Phase 2: 4 Phase 1: 3
Gastroenterology 8%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 1979-12-10
- Latest
- 2024-11-26
- Applications
- 4